Skip to main content
Fig. 1 | Journal for ImmunoTherapy of Cancer

Fig. 1

From: Immune monitoring technology primer: clinical validation for predictive markers

Fig. 1

A predictive biomarker example. The solid line shows the probability of 5-year survival under treatment; as the biomarker value increases from 0 to 10, the probability of survival decreases. The dashed line shows the probability of 5-year survival under a control; as the biomarker value increases from 0 to 10, the probability of survival increases. The optimal therapy is: treatment those with biomarker value below 5, and do not treat those with biomarker value above 5

Back to article page